These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9219755)

  • 1. Residual health status after Guillain-Barré syndrome.
    Bernsen RA; Jacobs HM; de Jager AE; van der Meché FG
    J Neurol Neurosurg Psychiatry; 1997 Jun; 62(6):637-40. PubMed ID: 9219755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual disability 10 years after falling ill in Guillain-Barré syndrome: a prospective follow-up study.
    Forsberg A; Press R; Holmqvist LW
    J Neurol Sci; 2012 Jun; 317(1-2):74-9. PubMed ID: 22425539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria.
    Fokke C; van den Berg B; Drenthen J; Walgaard C; van Doorn PA; Jacobs BC
    Brain; 2014 Jan; 137(Pt 1):33-43. PubMed ID: 24163275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What constitutes a 'good' recovery outcome in post-acute Guillain-Barré syndrome? Results of a nationwide survey of post-acute GBS sufferers in the United Kingdom.
    Davidson I; Wilson C; Walton T; Brissenden S; Campbell M; McGowan L
    Eur J Neurol; 2010 May; 17(5):677-83. PubMed ID: 20050884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections and course of disease in mild forms of Guillain-Barré syndrome.
    Van Koningsveld R; Schmitz PI; Ang CW; Groen J; Osterhaus AD; Van der Meché FG; Van Doorn PA
    Neurology; 2002 Feb; 58(4):610-4. PubMed ID: 11865140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the International Classification of Functioning, Disability and Health to describe patient-reported disability: a comparison of Guillain Barré syndrome with multiple sclerosis in a community cohort.
    Khan F; Amatya B; Ng L
    J Rehabil Med; 2010 Sep; 42(8):708-14. PubMed ID: 20809051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case-control study of drugs and other determinants as potential causes of Guillain-Barré syndrome.
    Stricker BH; van der Klauw MM; Ottervanger JP; van der Meché FG
    J Clin Epidemiol; 1994 Oct; 47(10):1203-10. PubMed ID: 7722555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact on work and private life after Guillain-Barré syndrome.
    Bernsen RA; de Jager AE; Schmitz PI; van der Meché FG
    J Neurol Sci; 2002 Sep; 201(1-2):13-17. PubMed ID: 12163188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term sensory deficit after Guillain-Barré syndrome.
    Bernsen RA; Jager AE; Schmitz PI; van der Meché FG
    J Neurol; 2001 Jun; 248(6):483-6. PubMed ID: 11499638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micturitional disturbance in patients with Guillain-Barré syndrome.
    Sakakibara R; Hattori T; Kuwabara S; Yamanishi T; Yasuda K
    J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):649-53. PubMed ID: 9408108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome.
    Bernsen RA; de Jager AE; Schmitz PI; van der Meché FG
    Neurology; 1999 Jul; 53(2):409-10. PubMed ID: 10430437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disability and health-related quality of life in Guillain-Barré syndrome during the first two years after onset: a prospective study.
    Forsberg A; Press R; Einarsson U; de Pedro-Cuesta J; Holmqvist LW
    Clin Rehabil; 2005 Dec; 19(8):900-9. PubMed ID: 16323390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.
    Clinical E; Neurology EP
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):218-24. PubMed ID: 9703176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome.
    Ann Neurol; 1997 Mar; 41(3):298-306. PubMed ID: 9066350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long-term functional status in patients with Guillain-Barré syndrome.
    Rudolph T; Larsen JP; Farbu E
    Eur J Neurol; 2008 Dec; 15(12):1332-7. PubMed ID: 19049550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barré syndrome associated with cytomegalovirus infection after kidney transplantation].
    Lloveras JJ; Larrue V; Delisle MB; Tack I; Icart J; Dupré C; Ton That H; Durand D; Suc JM
    Presse Med; 1994 Jun; 23(21):976-8. PubMed ID: 7937644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual subclinical impairment in patients who totally recovered from Guillain-Barré syndrome: impact on military performance.
    Burrows DS; Cuetter AC
    Mil Med; 1990 Sep; 155(9):438-40. PubMed ID: 2120633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience with Guillain-Barré syndrome in a neurological Intensive Care Unit.
    González P; García X; Guerra A; Arango JC; Delgado H; Uribe CS; Sará J; López de Mesa JC; Hernández O
    Neurologia; 2016; 31(6):389-94. PubMed ID: 25542501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.